ArticleInfection and drug resistance2026
Prospective Molecular and Phenotypic Characterization of
Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Urinary tract infections (UTIs) caused by extended-spectrum β-lactamase (ESBL)-producing Methods: A cross-sectional study was conducted at three tertiary-care hospitals in Tabriz, Iran (2025). We identified 100 non-duplicate Escherichia coli isolates recovered from ICU patients with UTIs using standard microbiological methods. Antimicrobial susceptibility testing was performed by the disk diffusion method according to CLSI 2024 guidelines. ESBL phenotype was confirmed using the combined disk test with Ceftazidime and Clavulanic acid. Genotypic detection of Results: Among 135 culture-positive urine specimens, Conclusion: ESBL-producing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.